Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Shugarman LR, Mack K, Sorbero ME, Tian H, Jain AK, Ashwood JS, Asch SM (2009) Race and sex differences in the receipt of timely and appropriate lung cancer treatment. Med Care 47:774–781
2. Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, Burau K, Du XL (2009) Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer 115(10):2199–2211
3. Shi R, Diaz R, Shi Z, Duvall E, Mills G (2016) The effect of payer status on survival of patients with stage I/II non-small cell lung cancer: NCDB 1998–2011. Anticancer Res 36(1):319–326
4. Anggondowati T, Ganti AK, Islam KM (2020) Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database. Transl Lung Cancer Res 9(4):1202
5. Medicare (2023) Understanding Medicare advantage plans. https://www.medicare.gov/Pubs/pdf/12026-Understanding-Medicare-Advantage-Plans.pdf. Accessed 6 Feb 2024